Fred Alger Management, LLC Maravai Lifesciences Holdings, Inc. Transaction History

Fred Alger Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $415 - $527	32 Added 0.04%	80,254 $1.12 Million
Q4 2022 Feb 14, 2023	SELL	$12.5 - $24.78 $173,800 - $344,541	-13,904 Reduced 14.77%	80,222 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $38,913 - $57,368	1,889 Added 2.05%	94,126 $2.4 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $270,815 - $389,642	10,396 Added 12.7%	92,237 $2.62 Million
Q1 2022 May 16, 2022	SELL	$24.46 - $40.92 $11,936 - $19,968	-488 Reduced 0.59%	81,841 $2.89 Million
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $105,700 - $138,738	-3,020 Reduced 3.54%	82,329 $3.45 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $45,632 - $75,168	1,240 Added 1.47%	85,349 $4.19 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $45.0 $36,160 - $50,130	-1,114 Reduced 1.31%	84,109 $3.51 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $27,683 - $41,299	-1,073 Reduced 1.24%	85,223 $3.04 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $2.11 Million - $2.66 Million	86,296 New	86,296 $2.42 Million

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.